sec filing
XB
NASDAQ · XBIO
Xenetic Biosciences, Inc.
Healthcare · Biotechnology
$2.19
Down-$2.08 (-48.71%)
Updated Sep 17, 2026, 10:23 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 3.76M
- P/E ratio
- -1.19
- Dividend yield
- 0.00%
- 52-week range
- $1.87 – $13.93
- Volume
- 1.51M
- Avg. volume
- 845.57K
Price performance
XBIO price history
1M range · 20 trading sessions · Daily adjusted prices
XBIO closed at $2.19 after 20 trading sessions, down 34.82% for the selected period.
- Last close
- $2.19
- Period change
- -34.82%
- Period low
- $2.19
- Period high
- $4.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $2.75 | $2.7888 | $1.87 | $2.19 | 1.51M |
| Sep 15, 2026 | $4.33 | $4.33 | $4.0882 | $4.27 | 5.88K |
| Sep 14, 2026 | $4.00 | $4.33 | $3.8522 | $4.33 | 66.84K |
| Sep 11, 2026 | $4.07 | $4.11 | $3.8367 | $3.90 | 37.65K |
| Sep 10, 2026 | $4.15 | $4.20 | $4.06 | $4.07 | 17.42K |
| Sep 9, 2026 | $4.26 | $4.30 | $4.11 | $4.215 | 26.82K |
| Sep 8, 2026 | $4.67 | $4.76 | $4.00 | $4.28 | 86.15K |
| Sep 4, 2026 | $4.73 | $4.9039 | $4.41 | $4.67 | 79.17K |
| Sep 3, 2026 | $4.27 | $4.9392 | $4.27 | $4.63 | 139.6K |
| Sep 2, 2026 | $4.23 | $4.4317 | $4.08 | $4.25 | 24.9K |
| Sep 1, 2026 | $4.20 | $4.25 | $4.00 | $4.23 | 26.58K |
| Aug 31, 2026 | $3.99 | $4.2999 | $3.9535 | $4.19 | 30.3K |
| Aug 28, 2026 | $4.01 | $4.06 | $3.90 | $3.98 | 19.59K |
| Aug 27, 2026 | $3.91 | $4.00 | $3.86 | $3.97 | 23.93K |
| Aug 26, 2026 | $3.78 | $3.88 | $3.70 | $3.86 | 22.42K |
| Aug 25, 2026 | $3.81 | $3.82 | $3.58 | $3.82 | 27.36K |
| Aug 24, 2026 | $3.74 | $4.05 | $3.5301 | $3.81 | 102.79K |
| Aug 21, 2026 | $3.36 | $3.73 | $3.18 | $3.59 | 84.26K |
| Aug 20, 2026 | $3.41 | $3.4103 | $3.28 | $3.39 | 9.27K |
| Aug 19, 2026 | $3.24 | $3.36 | $3.18 | $3.36 | 14.55K |
Latest XBIO news
The latest Smart Investors Daily articles mentioning XBIO.
Stock researchResearch & News · SEC Filings
Loading stock research…

